Testing exosome cream for pattern baldness
Part of Skin clinical trials.
This trial tests a new topical treatment called AGE ZERO™ EXOSOMES for men and women with pattern baldness (androgenetic alopecia). It aims to see if it's safe and effective for regrowing hair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are experiencing hair loss due to androgenetic alopecia (male or female pattern baldness).
- You have not used any hair loss treatments (like minoxidil, finasteride, or laser therapy) in the past 6 months.
- You do not have any open wounds, eczema, or psoriasis on your scalp.
- You have not had chemotherapy or radiation therapy in the last 6 months.
- You do not have a history of a blistering autoimmune skin disease (like pemphigus).
- You are not immunocompromised or have a low white blood cell count.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injections of exosomes (tiny particles from cells) can help regrow hair in men with mild to moderate male pattern baldness. It may offer a new treatment option without surgery.
This trial tests whether adding exosomes (tiny particles from cells that may help healing) to fractional laser therapy improves hair regrowth in men with male pattern baldness. You will be randomly assigned to get laser on your whole scalp, but only half will also get exosomes applied.
This study tests whether microneedling, a procedure that uses tiny needles to stimulate the scalp, can help treat male pattern baldness. It may help regrow hair in men with moderate to advanced hair loss.
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
This trial tests a cosmetic anti-hair loss product in men with early to moderate male pattern baldness. It looks at how well the product works and if it can help slow or reduce hair loss.
This study tests a new experimental biologic treatment, XVIE, for male and female pattern baldness. It aims to see if the treatment is safe and can help regrow hair in people with mild to moderate thinning.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.